1
Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a recombinant monoclonal antibody to Human CD51+CD61. It's a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.

Comments

Who Upvoted this Story